Research
Find research shared by the Owlstown community.
Role of pore-size distribution in coals to govern the Klinkenberg coefficient and intrinsic permeability
Publication · January 05, 2026
Tropical forests under drought: Vulnerability and ecophysiological strategies
ABSTRACT: Here we address the drought exposure and sensitivity of tropical forests and its tree ecophysiological strategies. Specifically, we assess the following questions based on a wide range of wet-to-dry forests by combining global databases ...
Project · January 05, 2026
Giants under drought: How the fate of large tropical trees is shaped by climate, hydrology, and hydraulics
The future of our planet depends on the persistence of large tropical trees. The largest 1% of trees (>50cm in diameter) store half of the carbon in tropical forests, and their death releases this carbon back into the atmosphere. However, the caus...
Project · January 05, 2026
Cardiometabolic and Obesity Risk Outcomes of Dawn-to-Dusk, Dry Intermittent Fasting: Insights from an Umbrella Review
Abstract
Background & aims
This umbrella review comprehensively and systematically summarizes meta-analyses on the impact of dawn-to-dusk, dry intermittent fasting of Ramadan (RIF) on cardiometabolic and glucose homeostasis indicators.
Methods...
Publication · January 05, 2026
Évaluation épidémiologique du cancer colorectal à l’ouest Algérien
Résumé
Introduction :
En Algérie, le cancer colorectal (CCR) représente la 3éme localisation en termes d’incidence après les cancers du sein et de la prostate, et de mortalité après les cancers du sein et du poumon. La présente étude avait pour o...
Publication · January 05, 2026
Disparités entre les sexes dans l’incidence du cancer colorectal
Abstract
Introduction :
En 2020, le nombre de cas incidents du cancer colorectal (CCR) chez l’homme représentait 53% de tous les nouveaux cas de CCR enregistrés en Algérie.
L’objectif de cette étude est d’évaluer les disparités par sexe dans l’i...
Publication · January 05, 2026
Tumor PD-L1 expression and Nivolumab efficacy: meta-analysis of phase III randomized clinical trials
Abstract
Introduction and aims
Nivolumab is a monoclonal antibody that binds to the PD-1 receptor expressed by activated T-cells activating thus an immune response against tumor cells. We conducted a meta-analysis to investigate the effect of tumo...
Publication · January 05, 2026
Tumor PD-L1 expression and Nivolumab efficacy in the treatment of cancer: a meta-analysis of phase III randomized clinical trials
Abstract
Introduction and aims:
Nivolumab is a fully-humanized IgG4 monoclonal antibody that binds to the PD-1 receptor expressed by activated T-cells blocking thus the immune checkpoint and activating an immune response to tumor cells [1]. We con...
Publication · January 05, 2026